EML4 and cancer: To determine whether EML4-ALK could alter RTK signal transmission, we expressed a light-sensitive fibroblast growth factor receptor (optoFGFR31) in STE-1 cancer cells, which express EML4-ALK variant 1 (V1)32 (Fig. 1E, Supplementary Fig. S1A).